Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence
שמור ב:
Cook, R., et al., Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence. Addiction, vol. 112, n. 6, 2017, p. 1077-1085.
Ref.
525793
מקום:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Anfetaminas, Tratamiento médico, Fármacos, Acción contra las drogodependencias, Efectos, Resultados, Recaída, Retención, EE.UU.
Drogodependencias, Drogas ilegales, Anfetaminas, Tratamiento médico, Fármacos, Acción contra las drogodependencias, Efectos, Resultados, Recaída, Retención, EE.UU.
פריטים דומים: Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence
- A REVIEW OF THE CLINICAL PHARMACOLOGY OF METHAMPHETAMINE
- RESPONDING TO TREATMENT DROPOUT: A REVIEW OF CONTROLLED TRIALS AND SUGGESTED FUTURE DIRECTIONS
- WITHDRAWAL SYMPTOMS IN ABSTINENT METHAMPHETAMINE DEPENDENT SUBJECTS
- COMPARISON OF COMPLETERS AND DROPOUTS IN PSYCHOLOGICAL TREATMENT FOR COCAINE ADDICTION
- Impulsivity is associated with treatment non-completion in cocaine- and methamphetamine-dependent patients but differs in nature as a function of stimulant-dependence diagnosis
- PREDICTING ADHERENCE TO TREATMENT FOR METHAMPHETAMINE DEPENDENCE FROM NEUROPSYCHOLOGICAL AND DRUG USE VARIABLES